MX2017000775A - Vacunas de meningococos. - Google Patents

Vacunas de meningococos.

Info

Publication number
MX2017000775A
MX2017000775A MX2017000775A MX2017000775A MX2017000775A MX 2017000775 A MX2017000775 A MX 2017000775A MX 2017000775 A MX2017000775 A MX 2017000775A MX 2017000775 A MX2017000775 A MX 2017000775A MX 2017000775 A MX2017000775 A MX 2017000775A
Authority
MX
Mexico
Prior art keywords
vaccines
meningocock
fhbp
diversity
variants
Prior art date
Application number
MX2017000775A
Other languages
English (en)
Spanish (es)
Inventor
Masignani Vega
Monica Giuliani Marzia
BIOLCHI Alessia
Brunelli Brunella
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of MX2017000775A publication Critical patent/MX2017000775A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
MX2017000775A 2014-07-17 2015-07-16 Vacunas de meningococos. MX2017000775A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14177563 2014-07-17
PCT/EP2015/066229 WO2016008961A1 (en) 2014-07-17 2015-07-16 Meningococcus vaccines

Publications (1)

Publication Number Publication Date
MX2017000775A true MX2017000775A (es) 2017-05-04

Family

ID=51178811

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000775A MX2017000775A (es) 2014-07-17 2015-07-16 Vacunas de meningococos.

Country Status (15)

Country Link
US (3) US11707513B2 (https=)
EP (1) EP3169358A1 (https=)
JP (2) JP6687597B2 (https=)
KR (2) KR20230012100A (https=)
CN (2) CN106659776A (https=)
AR (2) AR101225A1 (https=)
AU (2) AU2015289193A1 (https=)
BE (1) BE1022878B1 (https=)
BR (1) BR112017000519A2 (https=)
CA (1) CA2954729C (https=)
EA (1) EA038940B1 (https=)
IL (1) IL249823B (https=)
MX (1) MX2017000775A (https=)
SG (2) SG10201900041VA (https=)
WO (1) WO2016008961A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160127104A (ko) 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
JP6687597B2 (ja) 2014-07-17 2020-04-22 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 髄膜炎菌ワクチン
EP3169357B1 (en) 2014-07-17 2018-11-07 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
US10975131B2 (en) * 2015-10-27 2021-04-13 University Of Massachusetts Factor H-Fc immunotheraphy
CN107151270B (zh) * 2017-03-22 2018-07-31 武汉博沃生物科技有限公司 重组ΔfHbp-NadA融合蛋白载体及其制备方法和应用
CN108939061A (zh) * 2018-08-03 2018-12-07 北京智飞绿竹生物制药有限公司 一种多组分b群脑膜炎球菌疫苗及其制备方法
EP3607967A1 (en) * 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
US11014736B2 (en) 2019-04-18 2021-05-25 Altria Client Services Llc Sliding packs with flip top hinged lids
CN110804101A (zh) * 2019-11-08 2020-02-18 苏州微超生物科技有限公司 B群脑膜炎球菌相关融合蛋白、疫苗及其制备方法与应用
MX2022006299A (es) * 2019-11-25 2023-01-19 Univ Griffith Proteína inmunogénica contra una infección gonocócica.
GB202115151D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Methods
CN119792505A (zh) * 2023-10-10 2025-04-11 康希诺生物股份公司 一种抗脑膜炎球菌的免疫组合物及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747137B1 (en) 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
US6551795B1 (en) 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
PT2289545T (pt) * 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
GB0419408D0 (en) * 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
CA2792687A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
TR201802933T4 (tr) 2010-03-30 2018-03-21 Childrens Hospital & Res Center At Oakland Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
GB201120634D0 (en) 2011-11-30 2012-01-11 Univ Sheffield Adjuvant polypeptide
AU2013276083B2 (en) * 2012-06-14 2018-04-05 Institut Pasteur Vaccines for serogroup X meningococcus
GB201215005D0 (en) 2012-08-23 2012-10-10 Isis Innovation Stabilised meningitis vaccine
KR20160127104A (ko) 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
EP2916512B1 (en) 2014-03-07 2016-08-24 Mitsubishi Electric R&D Centre Europe B.V. Method for classifying a TCP connection carrying HTTP traffic as a trusted or an untrusted TCP connection
JP6687597B2 (ja) 2014-07-17 2020-04-22 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 髄膜炎菌ワクチン
EP3169357B1 (en) 2014-07-17 2018-11-07 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
CA3103741A1 (en) 2018-06-21 2019-12-26 Basf Se 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers

Also Published As

Publication number Publication date
US20230414736A1 (en) 2023-12-28
CA2954729A1 (en) 2016-01-21
AU2019201131A1 (en) 2019-03-07
BE1022878A1 (fr) 2016-09-30
EA038940B1 (ru) 2021-11-12
AR101225A1 (es) 2016-11-30
CA2954729C (en) 2023-08-22
CN106659776A (zh) 2017-05-10
JP2017522319A (ja) 2017-08-10
CN113827712A (zh) 2021-12-24
US20180214531A1 (en) 2018-08-02
SG10201900041VA (en) 2019-02-27
AU2019201131C1 (en) 2021-03-18
IL249823B (en) 2022-07-01
AR130778A2 (es) 2025-01-15
KR20230012100A (ko) 2023-01-25
IL249823A0 (en) 2017-03-30
WO2016008961A1 (en) 2016-01-21
US20260097107A1 (en) 2026-04-09
BE1022878B1 (fr) 2016-09-30
US12485164B2 (en) 2025-12-02
EA201692554A1 (ru) 2017-07-31
EP3169358A1 (en) 2017-05-24
JP2020117523A (ja) 2020-08-06
AU2015289193A1 (en) 2017-02-02
AU2019201131B2 (en) 2020-08-27
JP6687597B2 (ja) 2020-04-22
KR20170029615A (ko) 2017-03-15
US11707513B2 (en) 2023-07-25
BR112017000519A2 (pt) 2017-11-21
SG11201610946YA (en) 2017-01-27
KR102626831B1 (ko) 2024-01-22
JP7074793B2 (ja) 2022-05-24

Similar Documents

Publication Publication Date Title
MX2017000775A (es) Vacunas de meningococos.
CO2017002170A2 (es) Terapia de combinación para tratar un paramixovirus
SV2018005610A (es) Derivados de oxopiridina sustituidos
MX382033B (es) Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
PE20180260A1 (es) Metodos y kits para tratar la depresion
DK3513809T3 (da) Medicinsk sammensætning, som omfatter tivozanib
IL249061A0 (en) Combination, composition, and method of administering the combination or composition to animals
BR112015015891A8 (pt) Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
MX2018002990A (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
MX2017000395A (es) Vacunas contra virus influenza y usos de las mismas.
BR112017005314A2 (pt) inibidores de ssao derivados de imidazo[4,5-c]piridina
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
EA201492040A1 (ru) Бициклически замещённые урацилы и их применение
AR089993A1 (es) Macrociclos peptidomimeticos
BR112017006940A2 (pt) triazolopirazinonas como inibidores de pde1
EA201692541A1 (ru) Вакцины против вируса гриппа и их применения
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
CL2015001772A1 (es) Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
CO2018012180A2 (es) Métodos de tratamiento para enfermedades colestásicas y fibróticas
BR112017009792A2 (pt) anticorpos anti-pdgf-b e métodos de uso
BR112015027841A2 (pt) Método para umedecimento e/ou condicionamento do solo, concentrado da composição para tratamento do solo, e, uso de uma composição para tratamento do solo
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
BR112016015997A2 (pt) ?composições farmacêuticas que compreendem 15- hepe e métodos para tratar asma e distúrbios pulmonares com o uso das mesmas?
IL262929A (en) Composition, and application and pharmaceutical preparation thereof
BR112017011685A2 (pt) composições compreendendo 15-hepe e métodos de tratamento ou prevenção da fibrose usando as mesmas